Department of Surgery, Juravinski Hospital, McMaster University, Hamilton, ON, Canada.
Hamilton Health Sciences, Hamilton, ON, Canada.
Ann Surg Oncol. 2018 Oct;25(11):3214-3221. doi: 10.1245/s10434-018-6671-7. Epub 2018 Jul 26.
The aim of this study was to evaluate the incidence and risk factors for post-hospital discharge venous thromboembolism (VTE) following abdominal cancer surgery without post-discharge prophylaxis.
This was a single-center, prospective cohort study. Patients were evaluated at 1, 3, and 6 months from surgery for the presence of proximal deep vein thrombosis (DVT; screening ultrasound at 1 month and questionnaire at each visit). Cumulative VTE incidence with 95% confidence interval (CI) was estimated using Kaplan-Meier methods, and multivariable analysis was performed using a Cox proportional hazards model.
Of 284 patients enrolled, 79 (28%) underwent colorectal laparotomy, 97 (34%) underwent hepatobiliary laparotomy, 100 (35%) underwent gynecological laparotomy, and 8 (3%) underwent exploratory laparotomy without resection. All patients received pre- and postoperative inpatient prophylaxis. The cumulative incidence of VTE at 1 month was 0.35% (95% CI 0.05-2.48), 2.5% at 3 months (95% CI 1.19-5.15), and 7.2% at 6 months (95% CI 4.72-10.97). Screening ultrasound performed 4 weeks after surgery in 50% of patients was negative for thrombosis in all cases. Event distribution was similar according to the type of surgery (open/laparoscopic) and type of cancer. Seventeen (6.6%) patients died (95% CI 3.5-9.4) (two had a VTE-related death). Postoperative chemotherapy and Caprini score were significantly associated with VTE [hazard ratios 3.77 (95% CI 1.56-9.12) and 1.17 (95% CI 1.02-1.34), respectively].
The incidence of post-hospital discharge proximal DVT and/or symptomatic VTE following abdominal and pelvic cancer surgery appears to be low. The cumulative number of events increased at 6 months, but this was likely due to additional risk factors that were not related to surgery. Postoperative chemotherapy increases the risk of VTE.
本研究旨在评估腹部癌症手术后无出院后预防措施的情况下,出院后静脉血栓栓塞症(VTE)的发生率和风险因素。
这是一项单中心前瞻性队列研究。在手术后 1、3 和 6 个月,通过筛查超声(术后 1 个月)和问卷评估患者近端深静脉血栓形成(DVT)的存在情况(每次就诊时)。使用 Kaplan-Meier 方法估计累积 VTE 发生率和 95%置信区间(CI),并使用 Cox 比例风险模型进行多变量分析。
在 284 名入组患者中,79 名(28%)接受了结直肠剖腹手术,97 名(34%)接受了肝胆剖腹手术,100 名(35%)接受了妇科剖腹手术,8 名(3%)接受了无切除术的剖腹探查手术。所有患者均接受了术前和术后住院预防措施。术后 1 个月 VTE 的累积发生率为 0.35%(95%CI 0.05-2.48),3 个月时为 2.5%(95%CI 1.19-5.15),6 个月时为 7.2%(95%CI 4.72-10.97)。术后 4 周对 50%的患者进行了筛查超声检查,所有病例均未发现血栓。根据手术类型(开放/腹腔镜)和癌症类型,事件分布相似。17 名(6.6%)患者死亡(95%CI 3.5-9.4)(两名患者死于 VTE 相关死亡)。术后化疗和 Caprini 评分与 VTE 显著相关[风险比分别为 3.77(95%CI 1.56-9.12)和 1.17(95%CI 1.02-1.34)]。
腹部和骨盆癌症手术后出院后近端 DVT 和/或有症状 VTE 的发生率似乎较低。6 个月时累积事件数增加,但这可能是由于与手术无关的其他额外危险因素所致。术后化疗增加了 VTE 的风险。